The Anatomical Biological Value on Pretreatment (18)F-fluorodeoxyglucose Positron Emission Tomography Computed Tomography Predicts Response and Survival in Locally Advanced Head an...

por Ashamalla, Hani, Mattes, Malcolm, Guirguis, Adel, Zaidi, Arifa, Mokhtar, Bahaa, Tejwani, Ajay
Publicado 2014

Breast Cancer Subtype as a Predictor of Lymph Node Metastasis according to the SEER Registry

por Mattes, Malcolm D., Bhatia, Jay K., Metzger, Daniel, Ashamalla, Hani, Katsoulakis, Evangelia
Publicado 2015

The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry

por Mattes, Malcolm D., Lee, Jennifer C., Metzger, Daniel J., Ashamalla, Hani, Katsoulakis, Evangelia
Publicado 2015

Case series analysis of post-brachytherapy prostate edema and its relevance to post-implant dosimetry. Post-implant prostate edema and dosimetry

por Tejwani, Ajay, Bieniek, Eva, Puckett, Lindsay, Lavaf, Amir, Guirguis, Adel, Bennish, Aaron, Ashamalla, Hani
Publicado 2012

The effect of brain metastasis location on clinical outcomes: A review of the literature

por Kancharla, Pragnan, Ivanov, Alexander, Chan, Susie, Ashamalla, Hani, Huang, Raymond Y, Yanagihara, Ted K
Publicado 2019

Comparison study of intensity modulated arc therapy using single or multiple arcs to intensity modulated radiation therapy for high-risk prostate cancer

por Ashamalla, Hani, Tejwani, Ajay, Parameritis, Ioannis, Swamy, Uma, Luo, Pei Ching, Guirguis, Adel, Lavaf, Amir
Publicado 2013

A predictive model to guide management of the overlap region between target volume and organs at risk in prostate cancer volumetric modulated arc therapy

por Mattes, Malcolm D., Lee, Jennifer C., Elnaiem, Sara, Guirguis, Adel, Ikoro, N. C., Ashamalla, Hani
Publicado 2014

Treatment patterns and outcomes among women with brain metastases from gynecologic malignancies

por Cagino, Kristen, Kahn, Ryan, Pannullo, Susan, Ashamalla, Hani, Chan, Susie, Balogun, Onyinye, Thomas, Charlene, Christos, Paul J., Holcomb, Kevin, Frey, Melissa K., Chapman-Davis, Eloise
Publicado 2020

Information and communication technology in personalized medicine: a clinical use-case for hepatocellular cancer

por Berliner, Leonard, Lemke, Heinz U, van Sonnenberg, Eric, Ashamalla, Hani, Mattes, Malcolm D, Dosik, David, Hazin, Hesham, Shah, Syed, Mohanty, Smruti, Verma, Sid, Esposito, Giuseppe, Bargellini, Irene
Publicado 2014

A multidisciplinary management algorithm for brain metastases

por Ramos, Alexander, Giantini-Larsen, Alexandra, Pannullo, Susan C, Brandmaier, Andrew, Knisely, Jonathan, Magge, Rajiv, Wilcox, Jessica A, Pavlick, Anna C, Ma, Barbara, Pisapia, David, Ashamalla, Hani, Ramakrishna, Rohan
Publicado 2022

Model-guided therapy for hepatocellular carcinoma: a role for information technology in predictive, preventive and personalized medicine

por Berliner, Leonard, Lemke, Heinz U, vanSonnenberg, Eric, Ashamalla, Hani, Mattes, Malcolm D, Dosik, David, Hazin, Hesham, Shah, Syed, Mohanty, Smruti, Verma, Sid, Esposito, Giuseppe, Bargellini, Irene, Battaglia, Valentina, Caramella, Davide, Bartolozzi, Carlo, Morrison, Paul
Publicado 2014

Characterization of TR‐107, a novel chemical activator of the human mitochondrial protease ClpP

por Fennell, Emily M. J., Aponte‐Collazo, Lucas J., Wynn, Joshua D., Drizyte‐Miller, Kristina, Leung, Elisa, Greer, Yoshimi Endo, Graves, Paul R., Iwanowicz, Andrew A., Ashamalla, Hani, Holmuhamedov, Ekhson, Lang, Henk, Karanewsky, Donald S., Der, Channing J., Houry, Walid A., Lipkowitz, Stanley, Iwanowicz, Edwin J., Graves, Lee M.
Publicado 2022

Mitochondrial Protease ClpP is a Target for the Anticancer Compounds ONC201 and Related Analogues

por Graves, Paul R., Aponte-Collazo, Lucas J., Fennell, Emily M. J., Graves, Adam C., Hale, Andrew E., Dicheva, Nedyalka, Herring, Laura E., Gilbert, Thomas S. K., East, Michael P., McDonald, Ian M., Lockett, Matthew R., Ashamalla, Hani, Moorman, Nathaniel J., Karanewsky, Donald S., Iwanowicz, Edwin J., Holmuhamedov, Ekhson, Graves, Lee M.
Publicado 2019

Correction to “Mitochondrial Protease ClpP Is a Target for the Anticancer Compounds ONC201 and Related Analogues”

por Graves, Paul R., Aponte-Collazo, Lucas J., Fennell, Emily M. J., Graves, Adam C., Hale, Andrew E., Dicheva, Nedyalka, Herring, Laura E., Gilbert, Thomas S. K., East, Michael P., McDonald, Ian M., Lockett, Matthew R., Ashamalla, Hani, Moorman, Nathaniel J., Karanewsky, Donald S., Iwanowicz, Edwin J., Holmuhamedov, Ekhson, Graves, Lee M.
Publicado 2022